Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2020 / Cilt: 17 - Sayı: 4

The Role Of Tocolytic Agents and Calcium Channel Blockers (Nifedipine) In Preterm Birth Management

Preterm Doğum Yönetiminde Tokolitik Ajanlar ve Kalsiyum Kanal Blokerlerinin (Nifedipin) Yeri

Pages
621–628
Publication Date
2020-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, current literature on tocolytic agents and nifedipine used in the treatment of preterm delivery is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Preterm birth is an important risk factor for neonatal morbidity and mortality.
📊
Key Findings & Data:Calcium channel blockers (nifedipine) are safe and these agents are preferred frequently in medical treatment of preterm labor.
💡
Conclusion & Impact:In this review, current literature on tocolytic agents and nifedipine used in the treatment of preterm delivery is presented.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Preterm doğum · tokoliz · kalsiyum kanal blokerler

Abstract

Preterm birth is an important risk factor for neonatal morbidity and mortality. Calcium channel blockers (nifedipine) are safe and these agents are preferred frequently in medical treatment of preterm labor. Due to lack of license, they may use off-label in the treatment of preterm labor. In this review, current literature on tocolytic agents and nifedipine used in the treatment of preterm delivery is presented.

Özet

Preterm doğum, neonatal morbidite ve mortalite yönünden önemli bir risk faktörüdür. Kalsiyum kanal blokerleri (nifedipin) preterm doğum medikal tedavisinde kullanımı güvenlidir ve uluslararası kılavuzlarda sık tercih edilen ajanlardan birisidir. Ruhsatlanımı olmaması nedeniyle preterm doğum tedavisinde endikasyon dışı (off-label) kullanılmaktadır. Bu derlemede preterm doğum tedavisinde kullanılan tokolitik ajanlar ve nifedipin ile ilgili güncel literatür sunulmuştur.

🔖

Cite This Article

EROL, S. A., KIRBAŞ, A., USTUN, Y. (2020). The Role Of Tocolytic Agents and Calcium Channel Blockers (Nifedipine) In Preterm Birth Management. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 17 - Sayı: 4, 621–628. https://ajindex.com/articles/676635

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Practice Bulletin No. 171: Management of Preterm Labor. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Obstet Gynecol. 2016 Oct
  2. 128(4):e155-64. doi:10.1097/AOG.0000000000001711. Review. 2- Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications, Lancet 379:2162–2172, 2012. 3- Prevention and Management of Preterm Parturition. In: Resnik R, Lockwood CJ, Moore TR, Greene MF, Copel JA, Silver RM, et al. Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice, 8th Edition. Elsevier
  3. 2019, 679-700. 4-Preterm Birth. In: Cunningham FG, Leveno JK, Bloom SL, Dashe SJ, Hoffman BL, Casey BM, et al. Williams Obstetrics, 25th Edition. McGraw-Hill Education
  4. 2018, 804-828. 5-Matthews TJ, MacDorman MF, Thoma ME. Infant Mortality Statistics From the 2013 Period Linked Birth/Infant Death Data Set.Natl Vital Stat Rep. 2015 Aug 6
  5. 64(9):1-30. 6-Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016 Apr
  6. 21(2):68-73. doi: 10.1016/j.siny.2015.12.011. 7-Younge N, Goldstein RF, Bann CM, Hintz SR, Patel RM, Smith PB, Bell EF, et al. Survival and neurodevelopmental outcomes among periviable infants. N Engl J Med. 2017 Feb 16
  7. 376(7):617-628. doi: 10.1056/NEJMoa1605566. 8-Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 2008 Apr 17
  8. 358(16):1700-11. doi: 10.1056/NEJMra0707601. 9- Goldenberg RL. The management of preterm labor. Obstet Gynecol. 2002 Nov
  9. 100(5 Pt 1):1020-37. 10- Walker KF, Thornton JG. Tocolysis and preterm labour. Lancet. 2016 May 21
  10. 387(10033):2068-2070. doi: 10.1016/S0140-6736(16)00590-0 11- Preterm Labour and Birth.National Collaborating Centre for Women's and Children's Health (UK).London: National Institute for Health and Care Excellence (UK)
  11. 2015 Nov. 12- Lamont CD, Jørgensen JS, Lamont RF. The safety of tocolytics used for the inhibition of preterm labour. Review, Expert Opin Drug Saf. 2016 Sep
  12. 15(9):1163-73. doi: 10.1080/14740338.2016.1187128 13- Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1996 Oct
  13. 175(4 Pt 1):834-7. 14-Cotton DB, Strassner HT, Hill LM, Schifrin BS, Paul RH. Comparison betwee